MedTrace Logo

Eeva System Imaging Study

NCT02301637 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2015-07-13

No results posted yet for this study

Summary

The purpose of this clinical trial is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) for ongoing development and validation of the Eeva System.

Conditions

Interventions

DEVICE

Eeva™ Test

The Eeva System is indicated to provide adjunctive information on events occurring during the first two days of development that may predict further development to the blastocyst stage on Day 5 of development. This adjunctive information aids in the selection of embryo(s) for transfer on Day 3 when, following morphological assessment on Day 3, there are multiple embryos deemed suitable for transfer or freezing.

Sponsors & Collaborators

  • Progyny, Inc.

    lead INDUSTRY

Principal Investigators

  • Sheua Shen, MD · Vice President, Scientific and Medical Affairs

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301637 on ClinicalTrials.gov